Skip to the content
CrystalsFirst
Menu
CRYSTALSFIRST
MAGNET DISCOVERY
DRUG DISCOVERY
PROTEIN PRODUCTION
STRUCTURAL BIOLOGY
SMARTSOAK®
CO-CRYSTALLIZATION
DE NOVO CRYSTALLIZATION
COMPUTER-AIDED AND AI-DRIVEN DRUG DESIGN
COMPUTER-AIDED DRUG DESIGN (CADD)
AI-DRIVEN DRUG DESIGN (AIDD)
HIT IDENTIFICATION
SMARTSOAK® SCREENING
SMARTSPIN® SCREENING
OUR SCIENCE
PUBLICATIONS
BLOG
NEWS & EVENTS
ABOUT
CAREER
CONTACT
CrystalsFirst has demonstrated a closed-loop approach for generative molecular design.
Our MAGNET platform
combines proprietary g
enerative AI with SmartSoak
®
-technology
enables real-time, structure-based validation in an
iterative design loop
Actively delivering
validated chemical matter
in ongoing campaigns
each campaign runs on a dedicated generative AI model
full IP ownership
stays with the client
scalable across targets
molecular glues
and other challenging modalities
Subscribe to stay tuned